Page last updated: 2024-10-26

valproic acid and Experimental Hepatoma

valproic acid has been researched along with Experimental Hepatoma in 2 studies

Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Phillips, A1
Bullock, T1
Plant, N1
Jeannoda, VL1
Creppy, EE1
Beck, G1
Dirheimer, G1

Other Studies

2 other studies available for valproic acid and Experimental Hepatoma

ArticleYear
Sodium valproate induces apoptosis in the rat hepatoma cell line, FaO.
    Toxicology, 2003, Nov-05, Volume: 192, Issue:2-3

    Topics: Animals; Anticonvulsants; Apoptosis; Carcinoma, Hepatocellular; Caspase 3; Caspases; Cell Line, Tumo

2003
[Demonstration and partial purification of a convulsant from Cnestis glabra (Connaracea): effect on cells in culture].
    Comptes rendus des seances de l'Academie des sciences. Serie III, Sciences de la vie, 1983, Volume: 296, Issue:7

    Topics: Animals; Cell Line; Convulsants; DNA Replication; Kinetics; Liver Neoplasms, Experimental; Mice; Pla

1983